Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta (OI)

This study has been completed.
Eli Lilly and Company
Osteogenesis Imperfecta Foundation
Information provided by (Responsible Party):
Eric Orwoll, MD, Oregon Health and Science University Identifier:
First received: August 16, 2005
Last updated: October 30, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)